On 2025-05-14, Maze Therapeutics, Inc. (MAZE) announced earnings per share of $-1.15 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.76.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.67 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.76 | $-1.15 |
| 2025-03-31 | 2024-12-31 | $-7.60 | $-18.32 |